Zymergen Inc.
ZYDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001645842
Zymergen Inc. was delisted in 2022; its insiders filed their last Form 4 on Oct 21, 2022; 86 institutions reported holding it in 13F filings for Q3 2022, worth $168.1M in total; ARK Invest was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 86
- Q3 2022, +5 vs. previous quarter
- 13F value
- $168.1M
- Reported value at the end of Q3 2022
- Superinvestors holding
- 1
- At the end of Q3 2022
Superinvestors holding ZY, Q3 2022
1 superinvestor reports holding Zymergen Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Zymergen Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Singh EnakshiChief Financial Officer | SSale | −3.79K | $2.80 | −$10.6K | −0.8%462.2K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Singh EnakshiChief Financial Officer | SSale | −3.93K | $2.21 | −$8.68K | −0.8%466.0K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Kim MinaChief Legal Officer | SSale | −3.41K | $2.21 | −$7.54K | −1.1%298.4K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Serber ZachariahChief Science Officer | SSale | −3.27K | $2.21 | −$7.22K | −0.1%2.55M after | |
| Sep 1, 2022 (view filing) | Aug 30 | 2 days | Singh EnakshiChief Financial Officer | SSale | −15.4K | $2.27 | −$34.9K | −3.2%470.0K after | |
| Aug 15, 2022 (view filing) | Aug 11 | 4 days | Serber ZachariahChief Science Officer | SSale | −5.43K | $3.91 | −$21.3K | −0.2%2.55M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Serber ZachariahChief Science Officer | SSale | −2.97K | $2.61 | −$7.74K | −0.1%2.56M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Kim MinaChief Legal Officer | SSale | −3.09K | $2.61 | −$8.08K | −1.0%301.8K after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Serber ZachariahChief Science Officer | SSale | −2.80K | $1.32 | −$3.69K | −0.1%2.56M after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Kim MinaChief Legal Officer | SSale | −2.92K | $1.32 | −$3.86K | −0.9%304.9K after |
Top 10 13F holders, Q3 2022
The largest institutional positions in Zymergen Inc. at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SB Investment Advisers (UK) Ltd | 26,614,219 | $74.0M | 0.57% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 7,482,047 | $20.8M | 0.15% | +4,025,529+116.5% | Added |
| Morgan Stanley | 3,344,467 | $9.30M | 0.00% | +1,184,659+54.9% | Added |
| True Venture Partners IV, L.L.C. | 3,024,786 | $8.41M | 100.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 2,821,956 | $7.84M | 0.01% | 00.0% | Unchanged |
| Data Collective II GP, LLC | 2,448,901 | $6.81M | 80.63% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,436,119 | $6.77M | 0.00% | +555,992+29.6% | Added |
| Ergoteles LLC | 1,007,858 | $2.80M | 0.10% | +649,358+181.1% | Added |
| BlackRock Inc. | 933,154 | $2.60M | 0.00% | +511,943+121.5% | Added |
| Comprehensive Financial Management LLC | 769,477 | $2.14M | 0.06% | 00.0% | Unchanged |